Novo Nordisk recebe aprovação na china para comercializar Wegovy, medicamento de perda de peso

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Novo Nordisk recebe aprovação na china para comercializar Wegovy, medicamento de perda de peso

/jornal/2024/06/novo-nordisk-recebe-aprovacao-na-china-para-comercializar-wegovy-medicamento-de-perda-de-peso/

Novo Nordisk (BOV:N1VO34)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Novo Nordisk Charts.

Novo Nordisk (BOV:N1VO34)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Novo Nordisk Charts.

News

Real-Time news about Novo Nordisk (Brazil Bovespa Exchange): 0 recent articles

More News Articles

American Electric Power

IIVZ MSCI World Equal We...

Vontobel Financial Produ...

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions